Video

Visus CEO updates on lead product candidate, 2021 pipeline

Author(s):

OT Staff Reports
Conferences|AAO

Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.


See more AAO coverage here

Related Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Dr. Amir Ghanipour discusses light adjustable lenses for cataracts at EyeCon 2024
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
EyeCon 2024: Peter McDonnell, MD, and Laura Periman, MD, on the importance of integrating new knowledge into practice
Related Content
Key lectures and awards at the AAO 2024 meeting
October 11th 2024

Key lectures and awards at the AAO 2024 meeting

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
March 29th 2024

(EyePod) From idea to impact: Navigating ophthalmic innovation

MJH Life Sciences acquires EnVision Summit - ©dennisvdwater
October 9th 2024

MJH Life Sciences, parent of Ophthalmology Times, acquires EnVision Summit

Podcast: Talking about the anterior segment pipeline for 2023
March 29th 2023

Podcast: Talking about the anterior segment pipeline for 2023

Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting
Published: October 9th 2024 | Updated: October 9th 2024

Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting

AAO 2024 to “elevate” in Windy City
September 20th 2024

AAO 2024 to “elevate” in Windy City

© 2024 MJH Life Sciences

All rights reserved.